Selected Publications

Articles In Academic Journals

Year Title
2005 Identification of HLA-DQalpha and -DRbeta residues associated with susceptibility and protection to epithelial ovarian cancerHuman Immunology. 554-562.
2003 Immune responses to human tumors: Development of tumor vaccinesAnticancer Research. 1969-1996.
2002 Phase I study of intraperitoneal rh-IL-12 in patients with Mullerian, Gastrointenstinal Primary Malignancies and MesotheliomaClinical Cancer Research. 3686-3695.
2000 Clinical and biological effects of intraperitoneal injections of recombinant IFN-alpha and recombinant IL-2 with or without tumor infiltrating lymphocytes in patients with ovarian or peritoneal carcinomaClinical Cancer Research. 2268-2278.
2000 Expression of costimulatory molecules CD80 and CD86 and their receptors on tumor infiltrating lymphocytes from patients with ovarian carcinoma and other peritoneal carcinomatosisClinical and Experimental Immunology. 19-27.
1999 Identification of an IL-10-producing, HLA-DR-negative, monocyte subset in the malignant ascites of patients with ovarian carcinoma, which inhibits cytokine protein expression and proliferation of autologous T cellsJournal of Immunology. 6251-6260.
1999 Quantitative analysis of transforming growth factor-beta (TGF-?) and HLA class I and II in epithelial ovarian cancerClinical Cancer Research. 2498-2505.
1998 Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T-cell lines and established tumour cell linesClinical and Experimental Immunology. 172-180.
1998 Intraperitoneal immunotherapy of peritoneal carcinomatosis. Cytokines.Cellular and Molecular Therapy. 121-140.
1998 Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvisClinical Cancer Research. 799-809.
1998 Reverse transcription-PCR quantitation of cytokine responses in vivo from specimens containing small numbers of cells during immunotherapyJournal of Immunological Methods. 169-179.
1996 HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2Cellular Immunology. 116-128.
1996 Immunopharmacology and cytokine production of a low dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinomaJournal of Immunotherapy. 443-451.
1996 Use of a retroviral vector to study the trafficking patterns of purified ovarian tumor-infiltrating lymphocytes (TIL) used in intraperitoneal adoptive immunotherapy of ovarian cancer patients - A pilot studyHuman Gene Therapy. 1351-1365.


Year Title
1998 Progress toward tumor-specific immunity in carcinomas of the ovary and breastCancer in Women. Oxford, London, Berlin, Tokyo: Blackwell Science Publication.